<DOC>
	<DOCNO>NCT01578837</DOCNO>
	<brief_summary>The study combine Phase-I like ( safety ) Phase-II like ( efficacy ) double blind randomized placebo control trial . The objective investigate whether combination AG Rg3-enriched Korean Red ginseng add conventional medical treatment effective safe long-term management high blood pressure manage type 2 diabetes . Eighty-five subject type 2 diabetes concomitant high blood pressure ( key inclusion criterion : HbA1c ≥ 6.5 % - ≤ 8.0 % ) recruit study .</brief_summary>
	<brief_title>Combined Rg3-enriched Korean Red Ginseng American Ginseng Management Hypertension Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>age 40 75 year type 2 diabetes ( least 1 year duration , HbA1c ≥ 6.5 % ≤ 8.0 % , treat diet and/or oral hypoglycemic medication ) clinically diagnose treat hypertension accord Canadian Diabetes Association Clinical Practice Guidelines normal thyroid , kidney liver function female subject recruit study must postmenopausal absence menstruation ≥ 1 year take contraceptive precaution insulin therapy history angina , myocardial infarction stroke systolic blood pressure &gt; 160 mmHg and/or diastolic blood pressure &gt; 100 mmHg use ginseng within 1 month start study BMI &gt; 35 kg/m2 smoking cigarette alcohol intake &gt; 2 drinks/day recently give blood upcoming plan surgery GFR &lt; 60 mL/min/1.73m2 prolong QT ( &gt; 20 m ) interval assess ECG change use natural health product may effect blood pressure and/or diabetes weight change +/ 3 kg/month HIV infection , inflammatory bowel disease , celiac disease , heart disease , bleed disorder , sleep disorder , arrhythmia pregnant breastfeeding use anticoagulant ( exclude aspirin ) , antiplatelet , sedative , sympathomimetic , photosensitize antidepressant drug hormone replacement therapy , furosemide , morphine , glucocorticoid presence condition , opinion Qualified Investigator , might jeopardize health safety subject study personnel , adversely affect study result know sensitivity allergy test product placebo ingredient</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>